Sanofi
The Global Director Market Development and Strategy – Sickle Cell Disease at Sanofi is responsible for the Rilzabrutinib global market development strategy and activation for Sickle Cell Disease (SCD). This includes:
Direct experience in the SCD therapeutic area and a proven track record in building blockbuster brands are required.